proadifen has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galeotti, T | 1 |
| Eboli, ML | 1 |
| Palombini, G | 1 |
| van Rossum, GD | 1 |
| Kapoor, SC | 1 |
| Bogush, TA | 1 |
| Syrkin, AB | 1 |
2 other studies available for proadifen and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Inhibition of mitochondrial oxidative metabolism by SKF-525A in intact cells and isolated mitochondria.
Topics: Adenosine Triphosphate; Animals; Biological Transport, Active; Carcinoma, Ehrlich Tumor; Cytochrome | 1983 |
[Effect of phenobarbital and SKF 525-A on the toxic and therapeutic action of adriamycin in mice with Ehrlich ascites cancer].
Topics: Animals; Carcinoma, Ehrlich Tumor; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, P | 1985 |